Publication date: Available online 15 May 2017
Source:Trends in Biochemical Sciences
Author(s): Matthew D. Disney
Historically, translational inhibitors have been confined to anti-bacterials that globally affect translation. Lintner et al. demonstrate that small molecules can specifically inhibit translation of a single disease-associated protein by stalling the ribosome's nascent chain [1], opening up a new therapeutic strategy for 'undruggable' proteins.
http://ift.tt/2roqSg3
http://ift.tt/2pUjRkY
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου